Remdesivir, Exploring its Safety and Efficacy

Remdesivir, Exploring its Safety and Efficacy

Al Ritter

Remdesivir was manufactured by Gilead Sciences under the brand name Veklury. Its intended use was for treatment of Ebola and Hepatitis C in 2019 shortly before the Covid-19 outbreak.

In double blind randomly controlled trials Remdesivir was tested in conjunction with 3 other medicines for its efficacy against Ebola. Just 28 days into the trials it found that two of the four treatments were killing the test subjects, the most deadly one was Remdesivir that killed close to 50% of the patients. It was recommended that the two treatments be withdrawn. Subsequently the trials for Hepatitis C didn’t fare much better. Gilead Sciences was now stuck with a product and no disease to use it on.

We aren’t speaking yet about Covid this discussion so far is about safety. The safety statements were made in the New England Journal of Medicine and also in the NIH transcripts of the same trials.

Enter The Covid-19 response especially from the FDA and CDC and the NIAID. All these agencies knew about the dangers of Remdesivir and yet they were prepared to use it in *off label* use in treatment for Covid-19. The off label use part was intentionally used to force home the idea that the very same thing that those agencies claim about how Ivermectin can’t be used off label is now the very same thing they are doing with Remdesivir.

The FDA approved the EUA for Remdesivir based on a study supplied to them by Gilead Sciences of less than 1000 participants with no blind study group, making this study totally useless.

On the other hand The World Health Organization was doing their own “Solidarity Trials” that included 11,000 participants WITH control groups. In November 2020 after their study was done, they found no discernable difference in time of hospitalization or efficacy in the treatment of Covid-19 and therefore highly discouraged the use of Remdesivir.

Sadly the WHO never did a safety study on the drug only efficacy.

In Gilead Sciences own description of Remdesivir they speak to the danger to critical organs from its use. Some doctors say that renal failure is a byproduct of Covid-19 itself, and other scuff at the idea. But what does remain is that when used for treatment for Ebola almost 50% of the participants that used Remdesivir died from renal failure. Understand this was a year prior to the Covid-19 outbreak, so those deaths couldn’t be blamed on Covid!

It seems suspect to me not only how such a dangerous drug can stay on the market, but why would our government groups approve this drug for off label use when it’s efficacy and safety are in question.

I don’t understand their thinking when their own studies prove something different.

Read all my research here:

https://www.drugs.com/newdrugs/fda-approves-veklury-remdesivir-non-hospitalized-patients-risk-covid-19-progression-5772.html

https://www.forbes.com/sites/jvchamary/2021/01/31/remdesivir-covid-coronavirus/?sh=c3aef0c66c27

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250494/

New England Journal of Medicine:

https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910993?articleTools=true

https://kystandsup.org/remdesivir/